Blue Wolf Capital Partners Acquires European Pharmaceutical Manufacturing Facilities

Blue Wolf Capital Partners finalizes the acquisition of seven European pharmaceutical manufacturing facilities from Recipharm and plans to acquire Synerlab, aiming to establish a leading CDMO. The proposed combined platform intends to expand its commercial reach across Europe and beyond.